A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism

NCT07201298 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-10-01

No results posted yet for this study

Summary

This purpose of this study is to compare a new form of LASIK called Ray Tracing Guided LASIK to 3 other forms of corneal refractive surgery: 1. KLEx (KeratoLenticule Extraction) using the Zeiss Visumax 800 Laser, 2. WFO LASIK (Wavefront Optimized LASIK) using the Alcon EX500 Laser, and 3. Topography Guided LASIK (Contoura LASIK) also using the Alcon EX500 Laser.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

Ray-Tracing Guided LASIK

A form of LASIK where Ray-Tracing technology is used to create the surgical profile for treating the cornea.

DEVICE

Keratorefractive Lenticule Extraction (KLEx)

A form of corneal refractive surgery utilizing a femtosecond laser to create a lens shaped lenticule of corneal tissue that is removed through a small corneal incision.

DEVICE

WaveFront Optimized LASIK

A form of LASIK where the corneal treatment profile is modified to decrease induced Spherical Aberration.

DEVICE

Topography Guided LASIK

A form of LASIK where a corneal topography of the cornea is used to create the surgical profile for treating the cornea.

Sponsors & Collaborators

  • Hoopes Vision

    lead OTHER

Principal Investigators

  • Majid Moshirfar, MD · Hoopes Vision

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2028-09-30
Completion
2029-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07201298 on ClinicalTrials.gov